Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): A multicentre, open-label, phase 2 randomised controlled trial - Fehrenbacher, L; Spira, A; Ballinger, M (Lancet (London, England), 2016)
et al.